For information on this past event please contact Meetings Management

Second Circular and Provisional Conference Program

The Second International Conference

Modern Vaccines/Adjuvants Formulation 2007
Impact on Future Development
12-14 November 2007, The Alexander Hotel, Dublin, Ireland

The ever increasing drive to develop new vaccine therapies and their associated adjuvantation and delivery systems has major implications for the design/formulation/stabilization/preservation of modern vaccines and immunization strategies. Following the successful MVAF 2004 meeting held in Prague, the follow-up conference MVAF 2007 will offer an international forum for the discussion of all aspects of vaccine formulation and will focus on:

• Pharmaceutical development of vaccines and adjuvants

• Safety issues with special emphasis on delivery/administration issues

• National and international regulatory guidelines

MVAF 2007 will then assess the impact of all of the above on the future development/design of vaccines and adjuvants.

MVAF 2007 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.

Advisory Scientific Panel

Nathalie Garcon (GSK Belgium)
Jean Haensler (Sanofi Pasteur, France)
Elisabeth Sauzeat (Sanofi Pasteur, France)
Brian Ledwith (Merck, USA)
Robert Evans (Merck, USA)
Manmohan Singh (Novartis Vaccines, Emeryville, California, USA)
Jan-Willem van der Laan (RIVM, The Netherlands)
Lakshmi Khandke (Wyeth, USA)
Jim Robertson (NIBSC, UK)
Bruce Weniger (CDC, Atlanta, USA)
Rob Lambkin-Williams (Retroscreen Virology, London, UK)
Alex von Gabain (Intercell AG, Vienna, Austria)
Gwyn Davies (St. George’s University of London, UK)
Martin Friede (WHO, Geneva, Switzerland)
Ed Lavelle (Trinity College, Dublin, Ireland)
Vicky Pirzas (CSL Ltd., Victoria, Australia)
Greg Glenn (IOMAI Inc., Maryland, USA)

Closing date for poster abstract submissions Friday 5th October 2007

Sponsored by

Natural Standard is an integrative medicine database that provides high quality, evidence-based, professional and consumer information to some of the world’s most eminent institutions, such as the Mayo Clinic, the National Institutes of Health, and Harvard Medical School. The information included on the Natural Standard website is clinically relevant and undergoes multi-disciplinary review at academic centers across the country in order to promote unbiased and well-informed healthcare decisions. Individual databases include Herbs and Supplements, Health and Wellness, Comparative Effectiveness, Medical Conditions, Brand Names, Practitioners, Nutrition, and an Advanced Interactions Checker.